Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
$1.91
-6.4%
$4.02
$1.05
$12.50
$13.43M-0.99178,530 shs345,200 shs
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
$0.64
-6.7%
$1.27
$3.01
$13.40
$2.60M-0.0822,626 shs400,443 shs
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
$1.23
-3.1%
$1.00
$0.40
$1.65
$16.03M2.29901,889 shs254,638 shs
Beyond Air, Inc. stock logo
XAIR
Beyond Air
$2.86
-4.0%
$3.61
$2.75
$13.52
$13.83M0.25381,842 shs109,164 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
-6.37%-6.37%-51.40%-64.70%+190,999,900.00%
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
-20.44%-32.53%-54.42%-51.19%-93.72%
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
-3.15%-12.77%+13.89%+101.64%+11.82%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-4.03%-10.63%-19.57%-29.66%-75.34%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
N/AN/AN/AN/AN/AN/AN/AN/A
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
1.6583 of 5 stars
3.53.00.00.00.01.70.0
Beyond Air, Inc. stock logo
XAIR
Beyond Air
3.8467 of 5 stars
3.72.00.03.51.40.81.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
0.00
N/AN/AN/A
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
0.00
N/AN/AN/A
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
3.00
Buy$2.0062.60% Upside
Beyond Air, Inc. stock logo
XAIR
Beyond Air
3.40
Buy$23.67727.51% Upside

Current Analyst Ratings Breakdown

Latest BLAC, IINN, BDMD, and XAIR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/17/2025
Beyond Air, Inc. stock logo
XAIR
Beyond Air
D Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
7/17/2025
Beyond Air, Inc. stock logo
XAIR
Beyond Air
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$11.00
6/2/2025
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
Litchfield Hills Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
6/2/2025
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
Litchfield Hills Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy$2.00
(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
N/AN/AN/AN/AN/AN/A
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/AN/AN/AN/AN/A
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
N/AN/AN/AN/A$0.34 per shareN/A
Beyond Air, Inc. stock logo
XAIR
Beyond Air
$3.70M3.59N/AN/A$3.32 per share0.86
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
N/AN/A0.00N/AN/AN/AN/AN/A
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
-$11.05MN/A0.00N/AN/AN/AN/AN/A
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-$46.62M-$15.80N/AN/AN/A-1,258.46%-233.96%-113.92%8/12/2025 (Estimated)

Latest BLAC, IINN, BDMD, and XAIR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2025Q1 2026
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-$0.08N/AN/AN/A$1.75 millionN/A
6/17/2025Q4 2025
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-$2.80-$1.80+$1.00-$0.09$1.39 million$1.15 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
N/AN/AN/AN/AN/A
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/AN/AN/AN/A
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
N/AN/AN/AN/AN/A
Beyond Air, Inc. stock logo
XAIR
Beyond Air
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
N/AN/AN/A
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/AN/A
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
0.09
2.02
1.89
Beyond Air, Inc. stock logo
XAIR
Beyond Air
0.64
3.20
2.72
CompanyEmployeesShares OutstandingFree FloatOptionable
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
N/A6.58 million1.39 millionN/A
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/A4.04 million2.68 millionNot Optionable
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
2012.62 million8.91 millionNot Optionable
Beyond Air, Inc. stock logo
XAIR
Beyond Air
704.64 million3.74 millionOptionable

Recent News About These Companies

Beyond Air (NASDAQ:XAIR) Raised to Hold at Wall Street Zen
Beyond Air, Inc. (XAIR) - Yahoo Finance
Beyond Air Inc.

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Baird Medical Investment stock logo

Baird Medical Investment NASDAQ:BDMD

$1.91 -0.13 (-6.37%)
As of 08/1/2025 04:00 PM Eastern

Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.

Bellevue Life Sciences Acquisition stock logo

Bellevue Life Sciences Acquisition NASDAQ:BLAC

$0.64 -0.05 (-6.67%)
As of 08/1/2025

Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

Inspira Technologies OXY B.H.N. stock logo

Inspira Technologies OXY B.H.N. NASDAQ:IINN

$1.23 -0.04 (-3.15%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$1.24 +0.01 (+0.41%)
As of 08/1/2025 07:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.

Beyond Air stock logo

Beyond Air NASDAQ:XAIR

$2.86 -0.12 (-4.03%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$2.96 +0.10 (+3.50%)
As of 08/1/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.